Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Nightingale et al argue that all patients presenting to neurologists with cognitive impairment should undergo HIV testing.1 This view, prompted by a highly unusual case of a patient with HIV-related cognitive impairment, is based on the following reasoning: HIV is potentially treatable and testing is quick and relatively inexpensive; dementia is listed as an indication for testing by the British HIV Association, and suspected encephalitis is an indication for HIV testing in the Association of British Neurologists and British Infectious Association National Encephalitis guidelines; increasing age does not exclude HIV; and HIV is much more common than other ‘routinely’ tested potential causes of dementia, such as syphilis. The authors suggest that clinicians’ reluctance to test for HIV partly relates to misconceptions about the need for extended pre-test counselling.
Undoubtedly HIV can be associated with dementia, is easily tested and potentially treatable. However, before accepting that blanket HIV testing is warranted in all patients with dementia, it is important to consider how most patients with dementia present and the context in which they are seen. The vast majority of individuals presenting with cognitive impairment are elderly, with many—if …
Competing interests None.
Provenance and peer review Commissioned; internally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Biomarkers in dementia: clinical utility and new directions
- Alzheimer's disease: mimics and chameleons
- Test them all; an easily diagnosed and readily treatable cause of dementia with life-threatening consequences if missed
- Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer’s disease
- Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools
- Use of laboratory and imaging investigations in dementia
- Alzheimer’s disease
- The clinical assessment of the patient with early dementia
- Neuropathology of dementia in patients with Parkinson’s disease: a systematic review of autopsy studies